Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$618K Buy
4,810
+18
+0.4% +$2.11K 0.16% 67
2026
Q1
$576K Buy
4,792
+133
+3% +$15.4K 0.17% 62
2025
Q4
$490K Buy
4,659
+356
+8% +$33.4K 0.14% 67
2025
Q3
$361K Sell
4,303
-148
-3% -$12.2K 0.11% 81
2025
Q2
$352K Sell
4,451
-914
-17% -$72.7K 0.13% 72
2025
Q1
$482K Buy
5,365
+176
+3% +$16.4K 0.25% 50
2024
Q4
$516K Sell
5,189
-173
-3% -$17.8K 0.21% 59
2024
Q3
$609K Sell
5,362
-5
-0.1% -$594 0.26% 55
2024
Q2
$664K Sell
5,367
-60
-1% -$7.73K 0.33% 45
2024
Q1
$716K Buy
5,427
+1,093
+25% +$135K 0.37% 37
2023
Q4
$473K Buy
4,334
+307
+8% +$31.9K 0.28% 45
2023
Q3
$415K Sell
4,027
-75
-2% -$8.08K 0.31% 38
2023
Q2
$473K Sell
4,102
-540
-12% -$61.3K 0.37% 35
2023
Q1
$494K Sell
4,642
-303
-6% -$32.7K 0.41% 33
2022
Q4
$549K Buy
4,945
+925
+23% +$94.6K 0.52% 29
2022
Q3
$346K Buy
4,020
+143
+4% +$12.8K 0.35% 38
2022
Q2
$353K Sell
3,877
-8
-0.2% -$709 0.32% 45
2022
Q1
$319K Buy
3,885
+199
+5% +$15.7K 0.22% 66
2021
Q4
$282K Buy
+3,686
New +$294K 0.26% 59

Other funds holding MRK

Crown Wealth Group's MRK Position: Q2 2026 in Review

Crown Wealth Group increased its Merck (MRK) stake by 0.38% in Q2 2026, buying an estimated $2.11K and bringing the position to 4,810 shares worth $618K. The position accounts for 0.16% of the portfolio, ranked #67.

Crown Wealth Group first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $716K in Q1 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crown Wealth Group held 4,810 shares of Merck worth $618K as of Q2 2026.
  • Crown Wealth Group bought 18 Merck shares in Q2 2026, an estimated $2.11K.
  • Merck made up 0.16% of Crown Wealth Group's portfolio in Q2 2026, its #67 holding.
  • Crown Wealth Group first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Crown Wealth Group's Merck position peaked at $716K in Q1 2024.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crown Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.